Výsledky vyhledávání

Abstract S5-04: Ten year follow-up of BCIRG-006 comparing doxorubicin plus cyclophosphamide followed by docetaxel (AC→T) with doxorubicin plus cyclophosphamide followed by docetaxel and trastuzumab (AC→TH) with docetaxel, carboplatin and trastuzumab (TCH) in HER2+ early breast cancer

Publikováno v: Cancer Research. 76:S5-04

Background: BCIRG-006 was study designed to assess the relative efficacy and safety of two trastuzumab-based regimens compared to a standard (non-trastuzumab) regimen in the adjuvant treatment of early HER2+ breast cancer. We present the final, proto

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::7af83a45bef631e508f3a85937175c44
https://doi.org/10.1158/1538-7445.sabcs15-s5-04

Zobrazit plný text záznamu

Phase III Randomized Trial Comparing Doxorubicin and Cyclophosphamide Followed by Docetaxel (AC→T) with Doxorubicin and Cyclophosphamide Followed by Docetaxel and Trastuzumab (AC→TH) with Docetaxel, Carboplatin and Trastuzumab (TCH) in Her2neu Positive Early Breast Cancer Patients: BCIRG 006 Study

Publikováno v: Cancer Research. 69:62-62

Background: Evaluation of the long-term benefit of biologically-based regimens of trastuzumab in the early breast cancer population, and optimization of trastuzumab integration to maximize efficacy and minimize cardiac toxicity.Material and Methods:

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::371d734eac535b76817b3a1a2133e5d3
https://doi.org/10.1158/0008-5472.sabcs-09-62

Zobrazit plný text záznamu

Akademický článek

Treated ovarian cancer: comparison of MR imaging with serum CA-125 level and physical examination--a longitudinal study.

Autor: Low RN; Department of Diagnostic Radiology, Sharp and Children's MRI Center, Sharp Memorial Hospital, San Diego, CA 92123, USA., Saleh F, Song SY, Shiftan TA, Barone RM, Lacey CG, Goldfarb PM

Publikováno v: Radiology [Radiology] 1999 May; Vol. 211 (2), pp. 519-28.

Zobrazit plný text záznamu